Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research

M. Moossdorff, L.M. van Roozendaal, L.J.A. Strobbe, S. Aebi, D.A. Cameron, J.M. Dixon, A.E. Giuliano, B.G. Haffty, B.E. Hickey, C.A. Hudis, V.S. Klimberg, B. Koczwara, T. Kühn, M.E. Lippman, A. Lucci, M. Piccart, B.D. Smith, V.C.G. Tjan-Heijnen, C.J.H. van de Velde, K.J. Van ZeeJ B. Vermorken, G. Viale, A.C. Voogd, I.L. Wapnir, J.R. White, M.L. Smidt

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)

Abstract

BACKGROUND: In breast cancer studies, many different endpoints are used. Definitions are often not provided or vary between studies. For instance, "local recurrence" may include different components in similar studies. This limits transparency and comparability of results. This project aimed to reach consensus on the definitions of local event, second primary breast cancer, regional and distant event for breast cancer studies. METHODS: The RAND-UCLA Appropriateness method (modified Delphi method) was used. A Consensus Group of international breast cancer experts was formed, including representatives of all involved clinical disciplines. Consensus was reached in two rounds of online questionnaires and one meeting. RESULTS: Twenty-four international breast cancer experts participated. Consensus was reached on 134 items in four categories. Local event is defined as any epithelial breast cancer or ductal carcinoma in situ (DCIS) in the ipsilateral breast, or skin and subcutaneous tissue on the ipsilateral thoracic wall. Second primary breast cancer is defined as epithelial breast cancer in the contralateral breast. Regional events are breast cancer in ipsilateral lymph nodes. A distant event is breast cancer in any other location. Therefore, this includes metastasis in contralateral lymph nodes and breast cancer involving the sternal bone. If feasible, tissue sampling of a first, solitary, lesion suspected for metastasis is highly recommended. CONCLUSION: This project resulted in consensus-based event definitions for classification of recurrence in breast cancer research. Future breast cancer research projects should adopt these definitions to increase transparency. This should facilitate comparison of results and conducting reviews as well as meta-analysis.
Original languageEnglish
Article number288
Number of pages7
JournalJournal of the National Cancer Institute
Volume106
Issue number12
DOIs
Publication statusPublished - Dec 2014

Keywords

  • END-POINTS
  • CLINICAL-TRIALS
  • COMMON LANGUAGE
  • GUIDELINES

Cite this

Moossdorff, M., van Roozendaal, L. M., Strobbe, L. J. A., Aebi, S., Cameron, D. A., Dixon, J. M., Giuliano, A. E., Haffty, B. G., Hickey, B. E., Hudis, C. A., Klimberg, V. S., Koczwara, B., Kühn, T., Lippman, M. E., Lucci, A., Piccart, M., Smith, B. D., Tjan-Heijnen, V. C. G., van de Velde, C. J. H., ... Smidt, M. L. (2014). Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research. Journal of the National Cancer Institute, 106(12), [288]. https://doi.org/10.1093/jnci/dju288